Liprimar | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Liprimar
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Egis Atorvastatin - Dapagliflozin

Contact Supplier

Atorvastatin Calcium

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Atorvastatin

Contact Supplier

pharmacompass-2-m-2025-11-03

Liprimar

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

203 API Suppliers, 65 USDMF, 44 CEP/COS, 20 JDMF, 32 EU WC, 86 KDMF, 27 NDC API, 72 Listed Suppliers, $ API Reference Price

203 API Suppliers
65 USDMF
44 CEP/COS
20 JDMF
32 EU WC
86 KDMF
27 NDC API
72 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

89 Drugs in Development

89 Drugs in Development

INTERMEDIATES

27 Intermediate Suppliers

27 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2313 FDF Dossiers, 202 FDA Orange Book, 1447 Europe, 101 Canada, 127 Australia, 85 South Africa, 351 Listed Dossiers

2313 FDF Dossiers
202 FDA Orange Book
1447 Europe
101 Canada
127 Australia
85 South Africa
351 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 20MG BASE
TABLET;ORAL - EQ 40MG BASE
TABLET;ORAL - EQ 80MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 7 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 18 BASF, 1 BioSpectra, 1 CD Formulation, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 43 Direct Compression, 34 Disintegrants & Superdisintegrants, 29 Granulation, 28 Thickeners and Stabilizers, 27 Taste Masking, 26 Controlled & Modified Release, 23 Solubilizers, 22 Parenteral, 22 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 18 Topical, 13 Co-Processed Excipients, 10 Emulsifying Agents, 9 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

68 Fillers, Diluents & Binders
51 Coating Systems & Additives
43 Direct Compression
34 Disintegrants & Superdisintegrants
29 Granulation
28 Thickeners and Stabilizers
27 Taste Masking
26 Controlled & Modified Release
23 Solubilizers
22 Parenteral
22 Lubricants & Glidants
21 Chewable & Orodispersible Aids
19 Film Formers & Plasticizers
18 Topical
13 Co-Processed Excipients
10 Emulsifying Agents
9 API Stability Enhancers
7 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
2 Coloring Agents

DIGITAL CONTENT

162 News #PharmaBuzz

162 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 285 Regulatory FDF Prices, 51 Annual Reports

39 US Medicaid Prescriptions
285 Regulatory FDF Prices
51 Annual Reports

MARKET PLACE

60 APIs, 21 FDF Dossiers, 1 Intermediates

60 APIs
21 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

6 US Patents, 224 Health Canada Patents

6 US Patents
224 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 EDQM, 9 USP, 4 JP, 28 Others

6 EDQM
9 USP
4 JP
28 Others

ANALYTICAL

5 BioAnalytical Methods

5 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 179 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

6 All

01 1Y0001327

02 1Y0001328

03 1Y0001329

04 1Y0001330

05 1Y0001331

06 1Y0001332

filter CAS Number Reset all filters

6 All

01 1344423-98-9

02 5n/a

filter Reference Standard Reset all filters

6 All

01 1Atorvastatin calcium trihydrate

02 1Atorvastatin impurity A

03 1Atorvastatin impurity B

04 1Atorvastatin impurity C

05 1Atorvastatin impurity D

06 1Atorvastatin impurity E

Product Main Page

01

EDQM, Council of Europe

Atorvastatin impurity E

Paris Packaging Week

Not Confirmed

01

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin impurity E

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001332

Batch No : 4

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Atorvastatin impurity D

Paris Packaging Week

Not Confirmed

02

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin impurity D

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001331

Batch No : 5

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Atorvastatin impurity C

Paris Packaging Week

Not Confirmed

03

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin impurity C

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001330

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Atorvastatin impurity B

Paris Packaging Week

Not Confirmed

04

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin impurity B

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001329

Batch No : 4

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

EDQM, Council of Europe

Atorvastatin impurity A

Paris Packaging Week

Not Confirmed

05

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin impurity A

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001328

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

EDQM, Council of Europe

Atorvastatin calcium trihydrate

Paris Packaging Week

Not Confirmed

06

EDQM, Council of Europe

Paris Packaging Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Atorvastatin calcium trihydrate

CAS Number : 344423-98-9

Quantity Per Vial : 150 mg

Sale Unit : 1

Order Code : Y0001327

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.